Evidence map›Paper›PMID 36929186›Full record

ArticleApplied microbiology and biotechnology2023

The application of adenine deaminase in antibody affinity maturation.

Baole Qu, Yun Zhao, Lili An, Haiying Hang

Abstract read
PubMed Publisher
In one paragraph

Article in Applied microbiology and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Baole QuKey Laboratory for Protein and Peptide Pharmaceuticals, Institute of Biophysics, National Laboratory of Biomacromolecules, Chinese Academy of Sciences, Beijing, 100101, China.
Yun ZhaoKey Laboratory for Protein and Peptide Pharmaceuticals, Institute of Biophysics, National Laboratory of Biomacromolecules, Chinese Academy of Sciences, Beijing, 100101, China.
Lili AnKey Laboratory for Protein and Peptide Pharmaceuticals, Institute of Biophysics, National Laboratory of Biomacromolecules, Chinese Academy of Sciences, Beijing, 100101, China.
Haiying HangKey Laboratory for Protein and Peptide Pharmaceuticals, Institute of Biophysics, National Laboratory of Biomacromolecules, Chinese Academy of Sciences, Beijing, 100101, China. hh91@ibp.ac.cn.ORCID http://orcid.org/0000-0003-4351-6798
Chinese Academy of Sciences · CNInstitute of Biophysics · CN

Funding

National Key R&D Program of China 2021YFF0600803National Natural Science Foundation of China No. 31870923
6 · The paper itself

Abstract

Previously, we established a platform for antibody/protein affinity maturation based on CHO cell display. The gene of interest was mutated by activation-induced cytidine deaminase (AID), and then, a mutation library mainly containing G/C to A/T conversion was obtained by simply proliferating cells. However, the AID-induced G/C to A/T conversion limits the diversity space of the mutation library. In contrast to AID, adenine deaminase (ADA) can convert A/T to G/C. In this study, we demonstrated that ADA could efficiently induce random A/T to G/C mutations on the target gene in the CHO cell display and could be applied in affinity maturation. Our data also showed that more mutant types were obtained through the combined use of AID and ADA, thus offering an opportunity to acquire new mutants offering higher affinities than those obtained by only using AID. Examples presented in this study showed that ADA contributed to the improvement of antibody affinity either with or without AID in CHO display. KEY POINTS: • ADA is able to induce random mutations on antibody gene in mammalian cells. • ADA induces mutations on A/T bases to compensate AID which can induce mutation on G/C. • Combination of AID and ADA can increase mutation types and maturation efficiencies.

Indexed as

AminohydrolasesHydrolasesAnimalsAntibody AffinityCHO CellsCricetinaeCricetulusMutationadenine deaminaseAminohydrolasesHydrolasesActivation-induced cytidine deaminaseAdenine deaminaseAntibody affinity maturationCHO cell displayMutation type

Identifiers

PMID36929186
OpenAlexW4327676505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.